MetrioPharm AG
PrivateLast Round
VC Round
Oct 1, 2023
Est. Valuation
$163.04M
Total Funding Raised
$59.64M
Company Overview
MetrioPharm AG is a clinical-stage biopharmaceutical company that develops first-in-class, self-regulating immunomodulators for the treatment of inflammatory and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MetrioPharm AG Comparables
Compare MetrioPharm AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InflaRx N.V. | 74% | |
| Kymera Therapeutics, Inc. | 71% | |
| OMEICOS Therapeutics | 69% | |
MetrioPharm AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 1, 2023 | ||||
| Grant | Oct 12, 2022 | ||||
| VC Round | Oct 1, 2022 | ||||
| Grant | Nov 1, 2021 | ||||
| Series E | Oct 12, 2021 | ||||
Series D | Dec 11, 2018 |
MetrioPharm AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Duchenne UK | Grant |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors grew 79% MoM, from 616 to 1.1K.
- Sep 12, 2025
Professor Dr. Marcus Thelen appointed as Chief Scientific Officer.
MetrioPharm AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MetrioPharm AG's valuation, stock price, and market status.